Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $50.0000 (5.26%) ($47.5000 - $50.0000) on Fri. Apr. 26, 2013. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.45% (three month average) | RSI | 51 | Latest Price | $50.0000(5.26%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.1% a day on average for past five trading days. | Weekly Trend | CAPR declines -1.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XLY(3%) | Factors Impacting CAPR price | CAPR will decline at least -4.225% in a week (0% probabilities). IGOV(-2%) EMHY(-2%) REMX(-1%) GLD(-1%) EWY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.225% (StdDev 8.45%) | Hourly BBV | 0 () | Intraday Trend | 5.3% | | | |
|
1 - 5 Day Possible Target | $41.74(-16.52%) | 5 Day Moving Average | $48(4.17%) | 10 Day Moving Average | $48.03(4.1%) | 20 Day Moving Average | $48.4(3.31%) | To recent high | -32.2% | To recent low | 29.9% | Market Cap | $985m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |